Telomerase is not an oncogene - PubMed (original) (raw)

Review

. 2002 Jan 21;21(4):494-502.

doi: 10.1038/sj.onc.1205076.

Affiliations

• PMID: 11850774
• DOI: 10.1038/sj.onc.1205076

Review

Telomerase is not an oncogene

Calvin B Harley. Oncogene. 2002.

Abstract

In the decade since the telomere hypothesis of cellular aging was proposed, the two essential genes for human telomerase were cloned and characterized, allowing experimental proof of the causal relationships between telomere loss and replicative senescence, and telomerase activation and immortalization. These relationships were established using a variety of cultured human cell types from both normal and tumor tissues, and were largely confirmed in the telomerase knockout mouse. Taken together, the data provide strong support for the potential utility of telomerase detection and inhibition for cancer, and telomerase activation for degenerative diseases. The specificity of the promoter for the telomerase catalytic gene and the antigenicity of the protein product, hTERT, provide additional strategies for killing telomerase-positive tumor cells. Unfortunately, the strong link between telomerase and cancer has led some to confuse telomerase activation with cancer, and others to overstate the cancer risk of telomerase activation therapies for degenerative diseases. This review clarifies the difference between telomerase, which does not cause growth deregulation, and oncogenes, which do. It also addresses the concept of telomerase repression as a tumor suppressor mechanism early in life, with detrimental tissue degeneration and tumor-promoting consequences late in life. This extended view of the telomere hypothesis helps explain how telomerase inhibition can be therapeutic in cancer patients, while controlled telomerase activation for degenerative diseases may actually reduce, rather than increase, the frequency of age-related tumorigenesis.

PubMed Disclaimer

Similar articles

• Telomerase and human tumorigenesis.
  Stewart SA, Weinberg RA. Stewart SA, et al. Semin Cancer Biol. 2000 Dec;10(6):399-406. doi: 10.1006/scbi.2000.0339. Semin Cancer Biol. 2000. PMID: 11170862 Review.
• Telomerase: regulation, function and transformation.
  Dong CK, Masutomi K, Hahn WC. Dong CK, et al. Crit Rev Oncol Hematol. 2005 May;54(2):85-93. doi: 10.1016/j.critrevonc.2004.12.005. Crit Rev Oncol Hematol. 2005. PMID: 15843091 Review.
• Senescence and immortalization: role of telomeres and telomerase.
  Shay JW, Wright WE. Shay JW, et al. Carcinogenesis. 2005 May;26(5):867-74. doi: 10.1093/carcin/bgh296. Epub 2004 Oct 7. Carcinogenesis. 2005. PMID: 15471900 Review.
• Use of telomerase to create bioengineered tissues.
  Shay JW, Wright WE. Shay JW, et al. Ann N Y Acad Sci. 2005 Dec;1057:479-91. doi: 10.1196/annals.1356.037. Ann N Y Acad Sci. 2005. PMID: 16399914 Review.
• Events in the immortalizing process of primary human mammary epithelial cells by the catalytic subunit of human telomerase.
  Kim H, Farris J, Christman SA, Kong BW, Foster LK, O'Grady SM, Foster DN. Kim H, et al. Biochem J. 2002 Aug 1;365(Pt 3):765-72. doi: 10.1042/BJ20011848. Biochem J. 2002. PMID: 11978176 Free PMC article.

Cited by

• CTCF binds the proximal exonic region of hTERT and inhibits its transcription.
  Renaud S, Loukinov D, Bosman FT, Lobanenkov V, Benhattar J. Renaud S, et al. Nucleic Acids Res. 2005 Dec 2;33(21):6850-60. doi: 10.1093/nar/gki989. Print 2005. Nucleic Acids Res. 2005. PMID: 16326864 Free PMC article.
• Potent telomerase activators from a novel sapogenin via biotransformation utilizing Camarosporium laburnicola, an endophytic fungus.
  Küçüksolak M, Yılmaz S, Ballar-Kırmızıbayrak P, Bedir E. Küçüksolak M, et al. Microb Cell Fact. 2023 Apr 6;22(1):66. doi: 10.1186/s12934-023-02069-3. Microb Cell Fact. 2023. PMID: 37024895 Free PMC article.
• Telomerase Activation to Reverse Immunosenescence in Elderly Patients With Acute Coronary Syndrome: Protocol for a Randomized Pilot Trial.
  Maier R, Bawamia B, Bennaceur K, Dunn S, Marsay L, Amoah R, Kasim A, Filby A, Austin D, Hancock H, Spyridopoulos I. Maier R, et al. JMIR Res Protoc. 2020 Sep 23;9(9):e19456. doi: 10.2196/19456. JMIR Res Protoc. 2020. PMID: 32965237 Free PMC article.
• Protein kinase C delta blocks immediate-early gene expression in senescent cells by inactivating serum response factor.
  Wheaton K, Riabowol K. Wheaton K, et al. Mol Cell Biol. 2004 Aug;24(16):7298-311. doi: 10.1128/MCB.24.16.7298-7311.2004. Mol Cell Biol. 2004. PMID: 15282327 Free PMC article.
• Design and Development of Artificial Zinc Finger Transcription Factors and Zinc Finger Nucleases to the hTERT Locus.
  Wilson KA, Chateau ML, Porteus MH. Wilson KA, et al. Mol Ther Nucleic Acids. 2013 Apr 23;2(4):e87. doi: 10.1038/mtna.2013.12. Mol Ther Nucleic Acids. 2013. PMID: 23612114 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)